NCT00000329

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1

• Status: Withdrawn
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Colorado, Denver · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the abuse liability and examine the reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in buprenorphine-naloxone maintained volunteers

Detailed description

Ongoing study - results not available at this time

Conditions

• Heroin Dependence
• Opioid-Related Disorders

Interventions

Type	Name	Description
DRUG	Opioid-Related Disorders

Timeline

• Start date: 1999-04-01
• Primary completion: 1999-08-01
• Completion: 1999-08-01
• First posted: 1999-09-21
• Last updated: 2017-05-04

Locations

1 site across 1 country: United States